Poorer countries disadvantaged in procuring a Covid-19 vaccine


Global health leaders have all agreed that the Covid-19 vaccine should be deemed a global public good, and be a ‘people’s vaccine’.

Now that 2020 is nearing its final days, this does not mean that the coronavirus will end with it – meaning that the government still needs to ensure that there is enough medical resources available to safeguard the public’s health. Last week, the UK government issued emergency regulatory approval for one vaccine candidate.

However, this places poorer countries at a disadvantage because wealthier countries have pre-ordered enough doses of the vaccines to cover their populations several times over – leaving poorer countries having to rush to purchase the remaining doses. For more on this, we are joined by Fatima Hassan. She is a human rights lawyer and social justice activist….


News Headlines

Scroll to Top